SafPharm

History

2023: Agreement on the construction of a pharmaceutical plant in Murmansk

The Indian company Saffarm has agreed to build a pharmaceutical plant in the Murmansk region with an annual production of 1.3 billion units of drugs. By agreement with the Far East and Arctic Development Corporation (KRDV), more than 9.2 billion rubles will be invested in the project, including Indian capital, the press service of the regional government said in August 2023.

The pharmaceutical complex will provide the production of dosage forms mainly for hormonal, general and oncological purposes. Modern equipment will allow the production of drugs in the form of tablets, capsules, injections, ointments, drops and other forms, - the words of the general director of the company Kumar Divesh are quoted in the message.

Indian company "Saffarm" agreed on the construction of a pharmaceutical plant in Russia

He also noted that the plant will be able to meet domestic Russian demand by supplying medicines to state hospitals and selling through medical stores, and, if necessary, will export about 10% of the total production to the CIS countries.

During the implementation of the project, a one-story building of a pharmaceutical complex with an area of ​ ​ 14,500 square meters. m, which will be equipped with the necessary production equipment. Tax benefits, administrative preferences of the AZRF regime, as well as assistance and support from the Ministry for the Development of the Russian Far East, the KRDV and regional authorities will help to implement a significant project for both Russia and India as soon as possible with the most effective investment of funds.

According to the KRDV, today 645 projects with a declared investment of 817 billion rubles are being implemented in the Russian Arctic with state support, more than 24,300 jobs are being created. Residents of the AZRF actually invested almost 100 billion rubles in the economy of the macroregion. and created jobs for 7400 local residents.^[1]

Notes